Project Statistics: Papel neuroprotector de la P38 MAPK en la supresión de la inducción de genes proinflamatorios por compuestos de adenina.
Geo Map
Region
#
EU - Europe
37
AS - Asia, other
34
NA - North America
32
Unknown
14
Total
117
Country
#
US - United States of America
32
SG - Singapore
28
ES - Spain
16
NL - Netherlands
6
FI - Finland
5
RU - Russian Federation
5
CN - China
4
DE - Germany
4
HK - Hong Kong
1
IE - Ireland
1
other - Other Country
15
Total
117
City
#
Carbajosa de la Sagrada
14
Santa Clara
6
Singapore
6
Helsinki
5
Chandler
4
Braunschweig
2
Madrid
2
San Marcos
2
Shanghai
2
Beijing
1
other
73
Total
117
Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
Tot
2021
0 0
0 0 0 0
0 8 0 0
0 0
8
2022
0 0
0 0 0 0
0 0 0 0
0 1
1
2023
0 1
2 0 1 0
1 0 0 0
0 0
5
2024
12 0
0 0 0 1
3 15 5 1
0 1
38
2025
0 1
5 0 0 7
4 1 6 2
0 6
32
2026
4 1
1 3 20 0
0 0 0 0
0 0
29
Ever
117
Geo Map
| Region | # |
|---|---|
| EU - Europe | 37 |
| AS - Asia, other | 34 |
| NA - North America | 32 |
| Unknown | 14 |
| Total | 117 |
| Country | # |
|---|---|
| US - United States of America | 32 |
| SG - Singapore | 28 |
| ES - Spain | 16 |
| NL - Netherlands | 6 |
| FI - Finland | 5 |
| RU - Russian Federation | 5 |
| CN - China | 4 |
| DE - Germany | 4 |
| HK - Hong Kong | 1 |
| IE - Ireland | 1 |
| other - Other Country | 15 |
| Total | 117 |
| City | # |
|---|---|
| Carbajosa de la Sagrada | 14 |
| Santa Clara | 6 |
| Singapore | 6 |
| Helsinki | 5 |
| Chandler | 4 |
| Braunschweig | 2 |
| Madrid | 2 |
| San Marcos | 2 |
| Shanghai | 2 |
| Beijing | 1 |
| other | 73 |
| Total | 117 |
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Tot | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 8 | 0 | 0 | 0 | 0 | 8 |
| 2022 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 |
| 2023 | 0 | 1 | 2 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 5 |
| 2024 | 12 | 0 | 0 | 0 | 0 | 1 | 3 | 15 | 5 | 1 | 0 | 1 | 38 |
| 2025 | 0 | 1 | 5 | 0 | 0 | 7 | 4 | 1 | 6 | 2 | 0 | 6 | 32 |
| 2026 | 4 | 1 | 1 | 3 | 20 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 29 |
| Ever | 117 | ||||||||||||